Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating[...]
Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following[...]
05/01/2024 | Press release | Distributed by Public on 04/30/2024 18:08
Please select the service you want to use:
Smartlinks | Valerio Therapeutics SA | News | Health | Company News | Top Company News | Pharmaceuticals | Securities Issuers | Pharmaceutical Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Euronext Paris | Cboe Off Exchange | Turquoise
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact